Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma

We previously identified ZNF217 as an oncogenic driver of a subset of osteosarcomas (OSAs) using the Sleeping Beauty (SB) transposon system. Here, we followed up investigating the genetic role of ZNF217 in OSA initiation and progression through establishment of a novel genetically engineered mouse m...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Cancer Ther
Main Authors: Smeester, Branden A., Draper, Garrett M., Slipek, Nicholas J., Larsson, Alex T., Stratton, Natalie, Pomeroy, Emily J., Becklin, Kelsie L., Yamamoto, Kenta, Williams, Kyle B., Laoharawee, Kanut, Peterson, Joseph J., Abrahante, Juan E., Rathe, Susan K., Mills, Lauren J., Crosby, Margaret R., Hudson, Wendy A., Rahrmann, Eric P., Largaespada, David A., Moriarity, Branden S.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290861/
https://ncbi.nlm.nih.gov/pubmed/32999043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0369
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker